| 1 |
34933182 | LCN2 deficiency ameliorates doxorubicin-induced cardiomyopathy in mice. | 2022 Jan 15 |
2 |
| 2 |
35584053 | Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P-gp- and STAT3-Mediated Chemoresistance. | 2022 Jun 13 |
2 |
| 3 |
34600949 | Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma. | 2021 Dec |
2 |
| 4 |
31866378 | Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition. | 2020 Jan |
4 |
| 5 |
31942696 | STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells. | 2020 Jun |
1 |
| 6 |
31958751 | MiR-526b-3p mediates doxorubicin-induced cardiotoxicity by targeting STAT3 to inactivate VEGFA. | 2020 Mar |
3 |
| 7 |
32653978 | Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells. | 2020 Dec |
3 |
| 8 |
30472367 | Activation of cardiac TrkB receptor by its small molecular agonist 7,8-dihydroxyflavone inhibits doxorubicin-induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation. | 2019 Jan |
1 |
| 9 |
30675314 | Metformin selectively targets 4T1 tumorspheres and enhances the antitumor effects of doxorubicin by downregulating the AKT and STAT3 signaling pathways. | 2019 Feb |
6 |
| 10 |
29753615 | Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity. | 2018 Aug |
2 |
| 11 |
29078883 | Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer. | 2017 Nov |
1 |
| 12 |
26526549 | JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes. | 2016 May |
8 |
| 13 |
26980746 | Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors. | 2016 Apr 12 |
1 |
| 14 |
27323684 | Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein. | 2016 Jun 21 |
1 |
| 15 |
27340780 | Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3. | 2016 Jul 26 |
1 |
| 16 |
25660617 | Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy. | 2015 Mar 15 |
1 |
| 17 |
26255115 | Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α. | 2015 Oct |
4 |
| 18 |
26536361 | FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity. | 2015 |
3 |
| 19 |
24812279 | P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. | 2014 Jul 1 |
3 |
| 20 |
21738612 | Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. | 2011 |
1 |
| 21 |
14566054 | Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. | 2003 Oct 28 |
1 |
| 22 |
11524388 | Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. | 2001 Aug 28 |
2 |
| 23 |
10618415 | Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. | 2000 Jan 4 |
3 |